Back
Transgene SA 10K Form
Sell
37
TRGNF
Transgene SA
Last Price:
$1.00
Seasonality Move:
2516.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TRGNF News And Ratings
See the #1 stock for the next 7 days that we like better than TRGNF
TRGNF Financial Statistics
Sales & Book Value
| Annual Sales: | $37.9K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.01 |
| Price / Book: | 0.72 |
Profitability
| EPS (TTM): | -0.30450 |
|---|---|
| Net Income (TTM): | $-40M |
| Gross Margin: | $0 |
| Return on Equity: | -182.92% |
| Return on Assets: | -46.77% |
Transgene SA Earnings Forecast
Key Transgene SA Financial Ratios
-
The Gross Profit Margin over the past 17 years for TRGNF is 0.00%.
-
The Selling, General & Administrative Expenses for TRGNF have been equal to 22,150.40% of Gross Profit Margin.
-
The Research & Development expenses have been 94,064.38% of Revenue.
-
The Net Earning history of TRGNF is -96,955.41% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 13 years.
Transgene SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TRGNF |
| Website: | transgene.fr |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.57 |
| Quick Ratio: | 1.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TRGNF Technical Analysis vs Fundamental Analysis
Sell
37
Transgene SA (TRGNF)
is a Sell
Is Transgene SA a Buy or a Sell?
-
Transgene SA stock is rated a SellThe current Transgene SA [TRGNF] share price is $1.00. The Score for TRGNF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.